Whistleblower News From The Inside -- April 16, 2018

By the C|C Whistleblower Lawyer Team

Vote Leave broke spending limits on industrial scale, says former staffer – A former Vote Leave staffer has become the third whistleblower to publicly accuse the EU referendum campaign of exceeding spending limits “on an industrial scale.” In written evidence to the Electoral Commission seen by the Guardian, Mark Gettleson, a communications consultant, claims two of Theresa May’s political advisers were among the senior directors at Vote Leave involved in assisting the activities of a youth group, BeLeave, which was ostensibly a separate organisation. Vote Leave donated £625,000 to BeLeave which then spent the money on digital advertising in the last critical days before the vote. The evidence forms part of the basis of a legal opinion submitted to the digital, culture, media and sport committee that argues that a series of electoral offences may have been committed by Vote Leave. The Guardian

 NFL wants special investigator to look into concussion settlement fraud – The NFL is seeking the appointment of a special investigator to address what it claims is widespread fraud of its concussion settlement with former players — another step in a growing feud between the sides. In a filing Friday to the U.S. District Court of Eastern Pennsylvania, the league said nearly half the claims it has received have been red-flagged for audit. Of that, more than 400 have been rejected after an independent claim administrator found them to be fraudulent.The NFL is requesting the special investigator to assist the claim administrator and recommend sanctions. ESPN

Medical Device Cos. Deny FCA Suit’s Excess Blood-Test Cl Sanofi’s FCA Suit Docs Not All Privileged, Ex-Worker Says – A whistleblower told a Pennsylvania federal court Thursday that Sanofi should be required to hand over in discovery hundreds of documents it claims are protected by attorney-client privilege in a suit alleging it unlawfully marketed off-label uses of a cancer drug, violating the False Claims Act. Yoash Gohil, who worked as an oncology sales specialist for Aventis Pharmaceuticals before it changed its name to Sanofi, said that the company was attempting to claim that even documents that had only been forwarded to attorneys and communications that included third parties, among other things, were covered by attorney-client privilege. Law360